Dictyostelium discoideum is a cellular slime mold that serves as a valuable model organism for studying cell and developmental biology due to its simple life cycle and ease of handling . Recent studies suggest that Dictyostelium, along with other cellular slime molds, could be a source of novel compounds for pharmacological and medical research .
Recombinant Full Length Dictyostelium discoideum Reactive Oxygen Species Modulator 1 Homolog (Romo1) Protein is a protein that was fused to an N-terminal His tag and expressed in E. coli . The protein sequence consists of amino acids 1-128 (Q54M86) . Reactive Oxygen Species Modulator 1 (ROMO1) is a protein involved in the production of ROS by complex III of the mitochondrial electron transport chain . Other names for ROMO1 include hGlyrichin, Epididymis tissue protein Li 175, and Mitochondrial targeting GxxxG motif protein (MTGM2) . In humans, the mitochondrial protein consists of 79 amino acids and is located on chromosome 20q11.22 .
ROMO1 interferes with the production of reactive oxygen species (ROS); increased levels of this protein can lead to increased oxidative stress, potentially contributing to diseases, especially cancer . Homo sapiens Romo1 has two transmembrane domains (TMDs), each containing an α helix, connected by a basic loop . TMD1 has a hydrophobic α helix, while TMD2 contains polar amino acids (K58, T59, Q62, S63, T66, and T69) separated by other amino acids, with 3.6 amino acids in each α-helical turn . ROMO1 can stimulate cellular proliferation by producing ROS and activating signaling mediators like ERK, TGF-β, and their factors, including Smad2/3, extracellular matrix (ECM) proteins, and Epithelial mesenchymal transition (EMT) factors . ROMO1 influences these signaling pathways . Dickkopf1 (DKK1), a protein that interacts with and inhibits signaling pathways like Wnt/B-catenin, also affects ROMO1 gene expression, inhibiting its gene . Spermine, a polyamine involved in cellular and membrane protection, can also associate with ROMO1 due to its antioxidant effects .
Romo1 overexpression is associated with a poor response to treatment and short survival in patients treated with EGFR-TKIs .
| Low Romo1 (n = 71) | High Romo1 (n = 25) | p-value | |
|---|---|---|---|
| Response rate (CR+PR) | 60 (84.5) | 17 (68.0) | 0.0447 |
| Complete Response (CR) | 1 (1.4) | 0 (0) | |
| Partial Response (PR) | 59 (83.1) | 17 (68.0) | |
| Stable Disease (SD) | 9 (12.7) | 3 (12.0) | |
| Progressive Disease (PD) | 2 (2.8) | 5 (20.0) |
KEGG: ddi:DDB_G0286181
STRING: 44689.DDB0304361
Romo1 (Reactive Oxygen Species Modulator 1) is a highly conserved inner mitochondrial membrane protein that regulates mitochondrial ROS production and functions as a redox sensor. In Dictyostelium discoideum, Romo1 is encoded by gene DDB_G0286181, producing a protein of 128 amino acids .
The Dictyostelium Romo1 homolog shares functional similarities with human Romo1, particularly in:
Regulation of mitochondrial respiration and ROS production
Involvement in redox sensing
Potential role in mitochondrial dynamics
Unlike many other single-cellular model systems, Dictyostelium's genome encodes homologs of human disease genes, making its Romo1 protein valuable for studying fundamental mechanisms of ROS regulation that are conserved across species .
While functionally similar, key differences between Dictyostelium and human Romo1 include:
| Feature | Dictyostelium Romo1 | Human Romo1 |
|---|---|---|
| Protein Length | 128 amino acids | 79 amino acids |
| Chromosome Location | - | 20q11.22 |
| Alternative Names | - | hGlyrichin, Epididymis tissue protein Li 175, MTGM2 |
| Sequence Homology | Contains conserved functional domains | Reference sequence |
| Expression pattern | Developmental regulation | Tissue-specific expression |
The Dictyostelium Romo1 homolog contains the core functional domains necessary for ROS modulation but has additional amino acid sequences, possibly reflecting adaptation to Dictyostelium's unique lifecycle that alternates between unicellular and multicellular stages .
Several experimental approaches have proven effective:
Genetic manipulation systems:
Expression systems:
Functional assays:
Imaging techniques:
Based on successful expression protocols:
Expression system optimization:
E. coli is the preferred expression system, with BL21(DE3) or Rosetta strains showing good yield
Expression constructs should include a His-tag for efficient purification
Expression at lower temperatures (16-18°C) after IPTG induction improves protein solubility
Purification protocol:
Lyse cells in Tris/PBS-based buffer (pH 8.0) with 6% trehalose
Purify using nickel affinity chromatography
Further purification by size exclusion chromatography if higher purity is needed
Store as lyophilized powder or in buffer with 50% glycerol at -20°C/-80°C
Avoid repeated freeze-thaw cycles; aliquot for single use
Reconstitution considerations:
Reconstitute in deionized sterile water to 0.1-1.0 mg/mL
Add 5-50% glycerol (final concentration) for long-term storage
Protein concentration should be verified using standard Bradford or BCA assays
Researchers should be aware of important experimental limitations that can affect result interpretation:
Contradictory phenotypes:
Compensatory mechanisms:
Methodological considerations:
Recommended approach:
Studies reveal important similarities and differences:
| Parameter | Dictyostelium Romo1 | Human Romo1 |
|---|---|---|
| Basal respiration | Roco4/Romo1 knockout cells show increased basal respiration | Similar effect observed in human cells |
| Maximal respiration | Reduced in cells with PD-mutated Roco4/Romo1 | Reduced in cells with Romo1 mutations |
| Spare respiratory capacity (SRC) | Romo1 required for SRC maintenance | Romo1 required for SRC maintenance |
| Complex II/SDH activity | Specific loss of respiratory activity at Complex II/SDH | Similar effect, with specific loss of Complex II activity |
| ROS production | Increased ROS levels in Romo1-knockout cells | Contradictory reports on ROS levels depending on cell type and methodology |
Researchers have identified that Romo1 plays a critical role in maintaining spare respiratory capacity by regulating Complex II/SDH activity in both Dictyostelium and human systems. This suggests a highly conserved fundamental mechanism across evolutionary distance .
Dictyostelium provides several advantages as a model system for studying Romo1-related disease mechanisms:
Parkinson's disease research:
Dictyostelium Roco4 protein has been used as a model for human LRRK2 (Parkinson's disease-associated protein)
Roco4/Romo1 knockout cells show similar mitochondrial respiration alterations as seen in PD models
The G1179S mutation in Roco4 (equivalent to G2019S in human LRRK2) can be studied in Dictyostelium to understand disease mechanisms
Cancer biology applications:
Overexpression of Romo1 is associated with poor prognosis in several human cancers
Dictyostelium allows research on fundamental mechanisms of Romo1-mediated effects on cell proliferation and ROS production
The simplified system enables isolation of direct Romo1 functions from complex cancer microenvironments
Methodological approach:
Create chimeric proteins combining Dictyostelium and human domains to identify functional conservation
Use the Dictyostelium developmental cycle to investigate Romo1's role in different cellular states
Apply drug screening in Dictyostelium to identify compounds affecting Romo1 function before testing in more complex systems
When designing experiments to measure Romo1's effects on ROS production, researchers should consider:
Timing of measurements:
Acute vs. chronic effects show different patterns
Measure immediately after manipulation and at several timepoints to capture the complete response profile
Detection methods:
Experimental controls:
Include positive controls (antimycin A, rotenone) to validate detection systems
Use antioxidant treatments to confirm specificity of ROS signals
When using fluorescent markers, validate with quantitative biochemical assays
Interpretation challenges:
Recent structural analyses reveal important insights:
Transmembrane domains:
Channel properties:
Functional domains:
Experimental approach for structural studies:
Differentiating primary effects from secondary adaptations is crucial:
Recommended experimental design:
Implement temporal control systems (inducible knockdown/expression)
Use acute inhibition methods where available
Compare early vs. late timepoints after manipulation
Apply rescue experiments with wild-type and mutant versions
Specific measurements to distinguish effects:
Immediate changes in ROS levels (minutes to hours)
Early changes in mitochondrial membrane potential
Delayed changes in protein expression patterns
Long-term mitochondrial morphology alterations
Analysis approach:
Recent methodological developments include:
Microfluidic approaches:
Fluorescent biosensors:
Genetically encoded ROS sensors with improved specificity
Subcellular targeting to mitochondria or other compartments
Ratiometric measurements for quantitative analysis
Combined genetic approaches:
Mathematical modeling: